Top compounds associated with response to AKR1C1


Feature Type Standardized
Nominal ANOVA
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.026 0.5
mRNA Sunitinib GDSC1000 pan-cancer AAC -0.041 0.5
mRNA ML239 CTRPv2 pan-cancer AAC -0.027 0.5
mRNA BRD-K85133207 CTRPv2 pan-cancer AAC -0.028 0.5
mRNA FSC231 CTRPv2 pan-cancer AAC -0.054 0.5
mRNA Cytarabine CTRPv2 pan-cancer AAC -0.021 0.5
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.026 0.5
mRNA decitabine CTRPv2 pan-cancer AAC -0.02 0.5
mRNA AZD1480 CTRPv2 pan-cancer AAC -0.039 0.5
mRNA ML334 diastereomer CTRPv2 pan-cancer AAC 0.033 0.5
Download CSV